Regulation of prostate cancer cell survival by 5-lipoxygenase:Role of PKC-epsilon
5-脂氧合酶对前列腺癌细胞存活的调节:PKC-ε 的作用
基本信息
- 批准号:8517603
- 负责人:
- 金额:$ 22.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-12 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:12-HETEAgeAndrogensAnimal ModelAnimalsApoptosisArachidonate 5-LipoxygenaseBCL2 geneC57BL/6 MouseCancer ControlCell FractionationCell SurvivalCellsChemicalsDNA BindingDataDevelopmentDiazoxideDietDiseaseDominant-Negative MutationDown-RegulationEpithelial CellsGene TargetingGenetic TranscriptionGoalsGrowthHealthHumanHydroxyeicosatetraenoic AcidsImmunohistochemistryInduction of ApoptosisKnock-outKnockout MiceLeukotrienesMalignant NeoplasmsMalignant neoplasm of prostateMeasuresMediatingMediator of activation proteinMitochondriaMitosisMusNuclearNude MiceOmega-6 Fatty AcidsOncogenicOralOrganellesPhosphorylationPlayPrevention strategyPrevention therapyPreventiveProductionProstateProstatic NeoplasmsRegulationResearch Project GrantsResistanceRoleSeriesSignal TransductionSolventsTestingTherapeuticTimeToxic effectTransgenic OrganismsTranslationsTumor TissueUp-RegulationWestern BlottingXenograft procedureandrogen independent prostate canceraurora kinasebasedesignin vivoinhibitor/antagonistkillingsmaleneoplastic cellnovelnovel strategiesoverexpressionpreventpromoterprostate cancer cellprotein kinase C epsilonresearch studysurvivintreatment durationtreatment effecttumortumor growthtumor xenograft
项目摘要
DESCRIPTION (provided by applicant): Regulation of prostate cancer cell survival by 5-lipoxygenase: Role of PKC-epsilon Fresh experimental data suggest that induction of apoptosis in prostate cancer (PCa) cells by blocking critical survival mechanism(s) can be an attractive approach to prevent and treat PCa because clinically PCa is often characterized as slow growing where anti-mitogenic therapies are not much effective. However, the repertoire of survival mechanisms in PCa cells is not completely understood which largely contributes to the loss of battle against this disease. Emerging evidence from various studies has shown that PCa cells constitutively generate metabolites of 5-lipoxygenase (5-Lox) from arachidonic acid (an omega-6 fatty acid plentiful in Western diets), and inhibition of 5-Lox by specific inhibitors blocks production of 5-Lox metabolites and induces rapid apoptosis both in androgen-sensitive as well as androgen-independent PCa cells sparing non-cancer cells. Apoptosis is effectively prevented by the 5-Lox metabolites, 5(S)-HETE and 5-oxoETE, suggesting that these metabolites play an essential role in the survival of PCa cells. A critical role of 5-Lox in the survival of PCa cells has also been documented using siRNAs against 5-Lox. However, signaling mechanism(s) through which 5-Lox metabolites regulate PCa cell survival are not yet understood. Interestingly, 5-Lox is not expressed in normal prostate glands but is highly expressed in prostate tumors and in PCa cells, which together with a critical role of 5-Lox in the survival of PCa cells, suggests that 5-Lox may play an important role in the development of PCa. A recent pilot experiment showed that MK591, a specific inhibitor of 5-Lox activity, remarkably blocks prostate tumor growth in nude mice xenografts without any toxicity to animal health, suggesting that inhibition of 5-Lox could be an attractive approach for mounting specific attack on PCa cells without general toxicity. Thus, in vivo targeting of 5-Lox should be extensively carried out for a rapid translational development against PCa. The goals of this research project are to delineate the signaling mechanisms underlying regulation of PCa cell survival by 5-Lox, and to test the in vivo effects of targeting 5-Lox focusing on both the preventive and therapeutic aspects of PCa. These goals will be achieved by accomplishing the objectives of three specific aims. Specific Aim 1 will determine how 5-Lox activity regulates PCa cell survival involving PKC-epsilon (PKC5)-mediated signaling, because inhibition of 5-Lox inhibits PKC5 which is prevented by 5-Lox metabolites, and 5-Lox inhibition-induced apoptosis is prevented by activators of PKC5. Specific Aim 2 will determine whether inhibition of 5-Lox inhibits growth of prostate tumors in nude mice xenografts via induction of apoptosis in PCa cells. Specific Aim 3 will determine the role of 5-Lox in the development and progression of PCa by generating 5-Lox knockout transgenic (TRAMP) mice. Accomplishing the goals in this research project will help us to understand a novel mechanism of PCa cell survival, to determine whether 5-Lox plays a role in the development and progression of PCa, and to test whether targeting 5-Lox could be a novel mechanism-based strategy for prevention as well as treatment of PCa.
描述(由申请人提供):5-脂氧合酶对前列腺癌细胞存活的调节:PKC-β的作用新的实验数据表明,通过阻断关键存活机制诱导前列腺癌(PCa)细胞凋亡可能是预防和治疗PCa的一种有吸引力的方法,因为临床上PCa通常被表征为生长缓慢,其中抗有丝分裂疗法不是很有效。然而,PCa细胞中的存活机制尚未完全了解,这在很大程度上导致了对抗这种疾病的失败。来自各种研究的新证据表明,PCa细胞从花生四烯酸(西方饮食中丰富的ω-6脂肪酸)组成性地产生5-脂氧合酶(5-Lox)的代谢物,并且通过特异性抑制剂抑制5-Lox阻断5-Lox代谢物的产生并诱导雄激素敏感性以及雄激素非依赖性PCa细胞(保留非癌细胞)的快速凋亡。5-Lox代谢产物5(S)-HETE和5-oxoETE可有效防止细胞凋亡,表明这些代谢产物在PCa细胞的存活中起重要作用。5-Lox在PCa细胞存活中的关键作用也已使用针对5-Lox的siRNA记录。然而,5-Lox代谢物调节PCa细胞存活的信号传导机制尚不清楚。有趣的是,5-Lox在正常前列腺中不表达,但在前列腺肿瘤和PCa细胞中高度表达,这与5-Lox在PCa细胞存活中的关键作用一起表明5-Lox可能在PCa的发展中起重要作用。最近的初步实验表明,MK 591,一种5-Lox活性的特异性抑制剂,显著地阻断前列腺肿瘤在裸鼠异种移植物中的生长,而对动物健康没有任何毒性,这表明抑制5-Lox可能是一种有吸引力的方法,用于对PCa细胞进行特异性攻击而没有一般毒性。因此,5-Lox的体内靶向应该广泛地进行,以针对PCa进行快速翻译开发。本研究项目的目标是描述5-Lox调节PCa细胞存活的信号传导机制,并测试靶向5-Lox的体内作用,重点关注PCa的预防和治疗方面。这些目标将通过实现三个具体目标来实现。具体目标1将确定5-Lox活性如何调节涉及PKC-ε(PKC 5)介导的信号传导的PCa细胞生存,因为5-Lox的抑制会抑制PKC 5,而PKC 5会被5-Lox代谢物阻止,并且5-Lox抑制诱导的细胞凋亡会被PKC 5激活剂阻止。具体目标2将确定5-Lox的抑制是否通过诱导PCa细胞的凋亡来抑制裸鼠异种移植物中前列腺肿瘤的生长。具体目标3将通过产生5-Lox敲除转基因(TRAMP)小鼠来确定5-Lox在PCa的发展和进展中的作用。实现本研究项目的目标将有助于我们了解PCa细胞存活的新机制,确定5-Lox是否在PCa的发展和进展中发挥作用,并测试靶向5-Lox是否可以成为预防和治疗PCa的新机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAGADANANDA GHOSH其他文献
JAGADANANDA GHOSH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAGADANANDA GHOSH', 18)}}的其他基金
Neuroendocrine differentiation post anti-androgenic therapy: Role of Tribbles 2
抗雄激素治疗后的神经内分泌分化:Tribbles 2 的作用
- 批准号:
10659525 - 财政年份:2023
- 资助金额:
$ 22.86万 - 项目类别:
Regulation of prostate cancer cell survival by 5-lipoxygenase:Role of PKC-epsilon
5-脂氧合酶对前列腺癌细胞存活的调节:PKC-ε 的作用
- 批准号:
8331576 - 财政年份:2011
- 资助金额:
$ 22.86万 - 项目类别:
Regulation of prostate cancer cell survival by 5-lipoxygenase:Role of PKC-epsilon
5-脂氧合酶对前列腺癌细胞存活的调节:PKC-ε 的作用
- 批准号:
8184483 - 财政年份:2011
- 资助金额:
$ 22.86万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 22.86万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 22.86万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 22.86万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 22.86万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 22.86万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 22.86万 - 项目类别:
Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
- 批准号:
DP240103257 - 财政年份:2024
- 资助金额:
$ 22.86万 - 项目类别:
Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
- 批准号:
DP240100408 - 财政年份:2024
- 资助金额:
$ 22.86万 - 项目类别:
Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
- 批准号:
DP240100111 - 财政年份:2024
- 资助金额:
$ 22.86万 - 项目类别:
Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
- 批准号:
502786 - 财政年份:2024
- 资助金额:
$ 22.86万 - 项目类别:
Directed Grant